Real-World Evaluation of the Interaction Between Rifampicin and Warfarin: A Retrospective Observational Study
Conclusion: The warfarin–rifampicin interaction is clinically significant, as it can diminish warfarin’s anticoagulant effect, potentially compromising patient health outcomes. Close monitoring and individualized treatment plans are crucial for patients receiving both medications concurrently.
Saved in:
| Main Authors: | Lina Naseralallah, Dima Nasrallah, Somaya Koraysh, Ahmad R. Al-Qudimat |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Advances in Pharmacological and Pharmaceutical Sciences |
| Online Access: | http://dx.doi.org/10.1155/adpp/5607280 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of pharmacists in mitigating medication errors in the perioperative setting: a systematic review
by: Lina Naseralallah, et al.
Published: (2025-01-01) -
Analysis of clinical pharmacists’ interventions in a rehabilitation setting
by: Lina Naseralallah, et al.
Published: (2025-12-01) -
Comparison of the Incidence and Magnitude of Hyponatremia Among Patients With Poststroke Depression Receiving Either Escitalopram or Sertraline
by: Lina Naseralallah, et al.
Published: (2024-12-01) -
Interactions of warfarin with COVID-19 vaccine/drugs, monoclonal antibodies, and targeted anticancer agents from real-world data mining
by: Yan Gao, et al.
Published: (2024-11-01) -
Interaction of the Antibiotic Rifampicin with Lipid Membranes
by: Rui M. S. Santos, et al.
Published: (2025-02-01)